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Executive Summary 
 
Insulin is the primary medication used by health systems across the nation to 
provide glucose control to those patients who need it.  As this medication is generally 
available in a multi-dose vial, proper administration techniques should be used to 
minimize waste and optimize the cost effectiveness of the drug. Even though dosing 
guidelines for hospital use of insulin exist each institution has the opportunity to choose 
their administration technique.  In this paper I will to identify administration 
characteristics utilized by four different hospitals in the central Kentucky area, compare 
and contrast those techniques through data collection, and analyze the findings to 
determine the process that reduces the most waste and allows for the most cost 
effective use of the drug.  
 
This study focuses on insulin use processes at the following hospitals: Good 
Samaritan Hospital (Good Sam), the University of Kentucky Chandler Medical Center 
(UKCMC), Baptist Health-Richmond (BH), and the Lexington Veteran’s Affairs Hospital 
(VA). The purpose of the study is to gain an understanding of the use of insulin at Good 
Sam by collecting data over a two-week period and comparing that data to each of the 
other three hospitals. The data for these three hospitals was collected and studied 
throughout the completion of rotations at each institution. This comparison will allow for 
the identify of areas for improvement within Good Sam’s current insulin management 
process. Data collection measures included their insulin storage on the inpatient floors, 
insulin administration process, insulin purchasing process, and insulin waste process.  
 
Data collected at Good Sam was used to determine the amount of insulin waste 
(in milliliters) being collected each day over the two-week period. An average of that 
value was obtained and extrapolated to determine an approximate waste per six 
months. Using the current purchasing data for insulin, I determined the approximate 
cost of the insulin waste produced at Good Sam. Utilizing the knowledge of the insulin 
management process at Good Sam I was able to spend the next 18 weeks analyzing 
three other hospital’s insulin management process to determine ways to better utilize 
the insulin at Good Sam and to develop strategies to reduce insulin waste.  
 
This study serves as the basis for several recommendations to modify the insulin 
management process used at Good Sam. System wide nursing education on the proper 
technique to prepare insulin doses will be the foundation of these modifications. This 
education will include the preparation of the doses to occur at the Pyxis machines 
(automated dispensing cabinets) rather than the bedside. This minimizes the 
opportunity for distraction and increases the likelihood that vials will be replaced to their 
appropriate location to reduce waste. An additional recommendation includes storing 
vials of the of the insulin types that are used less frequently unopened in the fridge until 
needed. This will minimize the loss of product due to product expiration.  
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Background 
 
Everyday people intake nutrients to fuel their body. One of the most important of 
those nutrients is glucose. Glucose is created from the breakdown of sugars in the body 
and helps fuel the brain and other tissues to perform daily activities. Insulin is a 
hormone that is required by tissues in the body, such as adipose and muscle tissue, for 
glucose uptake (DiPiro 2014). Without insulin, the tissues would be unable to absorb 
glucose and the body would not be able to function correctly. Insulin is naturally 
produced in the body by beta cells in the pancreas (DiPiro 2014).However, there are 
circumstances where the beta cells become damaged, there are defects in the islet cell 
function, or a beta cell mass that can cause a decrease in insulin secretion (A Clark 
2001). When endogenous insulin secretion is disrupted the patient may require 
exogenous injections of an insulin analog. Insulin analog is a drug that may be 
necessary for patients who are either Type I diabetic or Insulin Deficient Type II diabetic 
since their bodies do not produce insulin naturally.   
 
There are five main categories of insulin analogs; rapid-acting insulin (insulin 
lispro, insulin aspart, and insulin glulisine), short-acting insulin (regular insulin), 
intermediate-acting insulin (NPH), long-acting insulin (insulin glargine, insulin detemir, 
and insulin degludec), and pre-mixed insulin (Humulin 70/30, Novolin 70/30, Novolog 
70/30, Humulin 50/50, and Humalog mix 75/25). While not all of these insulins are 
stocked in a hospital it is important for a hospital to carry a range from rapid-acting to 
long acting including pre-mixed insulins for its patients depending on the type of 
diabetes being treated.  
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In 2012, 29,100,000 Americans had diabetes. That is around 9.3% of the 
population. It was also found that approximately 1,400,000 Americans are diagnosed 
with diabetes every year (Prevention, National Diabetes Statistics Report: Estimates of 
Diabetes and Its Burden in the United States 2014). This could be attributed to the fact 
that Americans are developing diabetes at a younger age than before. As of 2010, 
Diabetes remained the 7th leading cause of death in the United States (Prevention, 
National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United 
States 2014). With the increasing diagnoses of diabetes and high death rate it has 
become even more important to assess the insulin management process we utilize to 
take care of the diabetic patients in the hospital. It was estimated that 22% of all hospital 
inpatient days were incurred by patients with diabetes and that their care accounted for 
nearly half of the $174,000,000,000 in medical expenditures for the disease 
(Association, Economic costs of diabetes in the United States in 2007 2008).  
 
Hospitals are spending more and more money each year on drugs for their 
patients. While outpatient medications can be profit producing for hospitals with the 
340B program, inpatient medications can be very costly. For instance, LantusÒ insulin 
is the second most costly drug used for inpatient care at the University of Kentucky 
Chandler Medical Center (UKCMC). UKCMC spends hundreds of thousands of dollars 
on purchasing LantusÒ annually (Hite 2017). LantusÒ is insulin glargine, which is a long 
acting basal insulin analog that is manufactured as 100 units/mL in 10mL vials or 3mL 
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pens. Most hospitals purchase the 10mL vials for inpatient use while the 3mL pens are 
utilized more for outpatients.  
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Problem Statement 
 
 
There are several problems that contribute to the difficult insulin management 
process that hospitals employ. First, alignment among the pharmacy and nursing must 
be coherent. With nursing being the last point in the insulin management process before 
it is administered to the patient, it is very important to have proper education for the staff 
on how the insulin should be administered. I have seen how the pharmacy department 
will implement a new strategy for administration of a drug and without proper education 
given, the nurses continue to follow the old protocols. Second, there has been no set of 
guidelines on the best practice for storing and administering insulin in the inpatient 
setting. Since there have been no best practice guidelines, each hospital has been 
developing its own systematic approaches to how to best store and administer insulin. 
This will allow my analysis of the insulin management process to help dissect quality 
improvements from various insulin management process and utilize those to create 
recommendations for the current Good Sam process.    
 
Last, each hospital can sign a contract to purchase insulin from a distributor or 
specific drug company. These contracts, which they purchase exclusively within their 
brands, can limit the quantities of insulin they are allowed to purchase from other 
companies. These contracts can help lower the costs of insulin and specifically the long-
acting insulin brands (LantusÒ and LevemirÒ). These contracts can be affected by the 
capture rate of the insulin administration in the hospital. Capture rate refers to the 
insulin being scanned into the patient’s electronic medical record (EMR) just before it is 
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administered to the patient. Scanning the insulin into the EMR is not only an extra 
security measure to ensure the right insulin is being administered to the appropriate 
patient, but it also allows for the hospital to bill the patient’s insurance for the amount of 
insulin that was given. There is a current problem in maintaining a high capture rate 
within the inpatient setting. Without the insulin administration being captured, the 
unaccounted for insulin is viewed similar to waste. This can lead to an increased 
purchasing price for the insulin and not qualify for the insulin to be purchased by a 
Group Purchasing Order (GPO).  
When it comes to purchasing insulin for inpatient use, the Wholesale Acquisition 
Cost (WAC) and Group Purchasing Order (GPO) accounts are used. To qualify as a 
GPO purchase the insulin must have been accounted for and captured in the EMR. If 
the hospital needs to buy 10 vials of insulin, but the EMR capture rate was only 50% 
meaning that only five of those vials were documented as given to the patient, then only 
five vials may be purchased using the GPO account and the other five must be 
purchased using the WAC account. This is a problem, because the GPO account 
pricing is approximately 80% -90% less than the pricing of the WAC account.   
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Literature Review  
 
The insulin management process can be different from hospital to hospital but 
there are a few rules that they all must follow.  The most important rule regarding the 
insulin vial is the “beyond use date” (BUD). While a hospital may choose to store insulin 
in its automated dispensing cabinets or in a refrigerator, it must keep consistent dates 
on those vials that are opened or stored outside of the refrigerator. If a vial is unopened 
and stored in the refrigerator then its BUD date would be the date on the manufacturer’s 
label. (DiPiro 2014) However, if the unopened insulin vial is placed in an automated 
dispensing cabinet such as a Pyxis or in a non-refrigerated bin, then the BUD dates 
would be as stated below in Table 1, Beyond Use Date for Insulins (Grajower 2003).  
 
 
Table 1 
Beyond Use Date for 
Insulins 
Opened Vial at Room 
Temperature (RT) or 
Refrigerated (days) 
Unopened Vial at RT 
(days) 
Rapid-acting Insulin 
Novolog (Aspart) 28 28 
Humalog (Lispro) 28 28 
Apidra (Glulisine) 28 28 
Short-acting Insulin 
Humulin R 28 28 
Novolin R 42 42 
Intermediate-acting Insulin (NPH) 
Humulin N 28 28 
Novolin N 42 42 
Long-acting Insulin 
Lantus (glargine) 28 28 
Levemir (detemir) 42 42 
Pre-mixed Insulin 
Novolog 70/30 28 28 
Novolin 70/30 42 42 
Humulin 70/30 28 28 
Humalog 50/50 28 28 
Humalog 75/25 28 28 
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As Table 1 illustrates most insulin vials are to be given a BUD of 28 days from 
the time they are opened or stored at room temperature.  Insulin vials should never be 
stored in the freezer, in direct sunlight, or in a glove compartment in a car (Association, 
Insulin Storage and Syringe Safety 2014).  
 
Previous studies have looked at the use of insulin pens in an inpatient setting. 
One study looked at the conversion from 10mL stock vials to 3mL individual patient 
supply pens. The conversion was associated with a 11.5% decrease in the number of 
insulin units purchased. However, a cost increase of 6.8% was associated with 
changing the long-acting insulin from 10mL vials to 3mL patient specific pens 
(Edmondson G 2014). It is very important to note that if a hospital chooses to use 
insulin pens that each pen can be used for only one patient.  This is due to macroscopic 
blood regurgitation into an insulin pen cartridge that is sometimes observed. The blood 
regurgitation could lead to the spread of diseases such as HIV and Hepatitis B. A study 
tested 146 insulin pens and detected Hemoglobin in 6 of the insulin pens (Sonoki K 
2001).  
 
Insulin vials can be multi-dose vials if they are only kept and accessed in a 
dedicated medication preparation area and away from immediate patient treatment 
areas. The purpose of the strict guidelines is to prevent the inadvertent contamination of 
the insulin vials through direct or indirect contact with potentially contaminated surfaces 
or equipment that could lead to infections in subsequent patients. If an insulin vial enters 
an immediate patient treatment area, then it should be deemed for that specific patient’s 
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use only (Prevention, Frequently Asked Questions (FAQs) regarding Safe Practices for 
Medical Injections 2016). 
 
The Institute for Safe Medication Practices (ISMP) distributed an article in 2013 
reviewing the safe use of insulin vials. In that article, the ISMP indicated that the cross-
contamination risk associated with using insulin pens in the hospital inpatient setting 
was too high and they recommended not to use them in the inpatient setting. The ISMP 
also suggested that the pharmacy should prepare, label and dispense patient-specific 
insulin doses in insulin syringes (Institue for Safe Medication Practices 2013). 
 
While previous studies have looked at the beyond use date for insulin vials, the 
use of insulin pens or insulin vials in the inpatient setting, the proper storage for insulin 
vials, and the safe use of insulin vials; none of the studies has looked at the full insulin 
management process to determine which processes are the most efficient.  
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Research Design 
The purpose of this study is to collect specific data from Good Sam on their 
insulin management process to analyze and find room for improvements. Then use 
observations from three other hospitals on their insulin management process to 
recommend improvements for Good Sam’s insulin management process.  
 This study started with a 14-day control period at Good Sam Hospital. During 
those 14 days, I collected and recorded all the insulin vials and associated milliliters of 
insulin that were sent back from the inpatient floors to the pharmacy for disposal. I also 
oversaw ensuring that all the automated dispensing cabinets were adequately stocked 
with insulin and that each insulin received the appropriate 28 day beyond use dating 
when it was at room temperature. Once I had aggregated all the data I had collected in 
the 14-day control period, I arranged a meeting with the pharmacy director to go over 
the Wholesale Acquisition Cost (WAC) and Group Purchasing Order (GPO) cost of 
each insulin that was on formulary. We also discussed the importance of having the 
insulin tracked and shown in the computer as the patient having received their dose of 
insulin. This relates to the capture rate of the insulin to incorporate into the billing 
process to determine the purchase price.   
 
After the 14-day control period at Good Sam, I spent two days each at three 
different hospitals walking through their insulin management process with either their 
clinical director, inpatient services director, or their operations director. At each site, I 
gathered the same data as at Good Sam, such as storage of the insulin (whether it was 
stored in an automated dispensing cabinet or in the refrigerator), administration process 
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(from when the nurse removes the insulin from its storage location to the administration 
of the insulin dose to the patient), and their insulin waste production.  I also added a 
new data point to collect based on my discussion with the pharmacy director of 
operations, the capture rate of insulin administration to the patient. (Turner 2017)   
 
The purpose of the study was to gain a full understanding of Good Sam’s insulin 
management process and then to analyze and compare findings at similar hospitals’ 
insulin management process to look for areas of improvement upon the current process 
at Good Sam. Determining best practice methods would not only help Good Sam but 
could help foster the identification of other hospital insulin management processes to 
improve.  
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Results 
 At Good Samaritan Hospital, the pharmacy stocks two 3mL Humalog vials, two 
10mL Lantus vials, one 3mL Humulin 70/30 vial, one 3mL Humulin N vial and two 3mL 
Humulin R vials on average in each of the main inpatient ward Pyxis machines. Each 
vial is dated with a 28-day BUD upon removal from the refrigerator in the pharmacy 
before it is sent up to the floor to be stored in the Pyxis machine. During my first day of 
the 14-day control period, I watched as nurses pulled full insulin vials from the Pyxis, 
drew up one milliliter and then placed the rest of the vial in the return to pharmacy bin to 
be disposed. At the end of day 1 I had collected 3 Humulin R vials, 3 Lantus vials, 1 
70/30 Humulin vial, 1 Humulin N vial and 3 Humalog vials as shown in Figure 1 below.  
 
Figure 1: Day 1 Insulin Waste 
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While it may not seem like much, the WAC value of the insulin in Figure 1 is 
$1,113.23. After continuing for a full fourteen days, I had collected over 70 vials of 
insulin and Table 2 illustrates exactly what was collected on each day.  
 
Table 2 
Insulin Waste in Vials 
  
DAY   Lantus 70/30 Humalog 
Humulin 
R 
Humulin 
N 
1 3 1 3 3 1 
2 0 0 4 2 1 
3 0 0 5 2 0 
4 1 0 2 1 0 
5 0 0 2 1 0 
6 0 0 4 1 0 
7 2 1 3 2 0 
8 1 0 2 0 0 
9 0 0 2 1 1 
10 0 0 2 0 1 
11 0 0 1 1 0 
12 0 1 4 1 0 
13 1 0 4 0 0 
14 2 0 2 0 0 
Total  10 3 40 15 4 
 
There were 72 vials collected after being returned to the pharmacy for disposal. 
The largest percentage of vials were the Humalog which made up 56% of the returned 
insulin vials. Humalog is also the second most expensive insulin vial to purchase via 
WAC ($71.07) or GPO ($14.24) (Lakarosky 2017).  Table 3 shows the waste broken 
down by dollar units instead of by vials as listed in Table 2.   
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TABLE 3 
Daily Waste in WAC Dollars 
 
DAY   Lantus 70/30 Humalog Humulin R Humulin N Total 
1  $693.12   $41.38   $213.21   $124.14   $41.38  
 
$1,113.23  
2  $-     $-     $284.28   $82.76   $41.38   $408.42  
3  $-     $-     $355.35   $82.76   $-     $438.11  
4  $231.04   $-     $142.14   $41.38   $-     $414.56  
5  $-     $-     $142.14   $41.38   $-     $183.52  
6  $-     $-     $284.28   $41.38   $-     $325.66  
7  $462.08   $41.38   $213.21   $82.76   $-     $799.43  
8  $231.04   $-     $142.14   $-     $-     $373.18  
9  $-     $-     $142.14   $41.38   $41.38   $224.90  
10  $-     $-     $142.14   $-     $41.38   $183.52  
11  $-     $-     $71.07   $41.38   $-     $112.45  
12  $-     $41.38   $284.28   $41.38   $-     $367.04  
13  $231.04   $-     $284.28   $-     $-     $515.32  
14  $462.08   $-     $142.14   $-     $-     $604.22  
Total   $2,310.40   $124.14   $2,842.80   $620.70   $165.52  
 
$6,063.56  
 
Looking at the WAC dollar amounts listed above in Table 3 you can see that 
Humalog and Lantus are accounting for almost 85% of the waste in WAC dollars. Table 
4 represents the various insulin vials on formulary along with their current WAC and 
GPO pricing.   
Table 4 
Purchasing 
Costs Lantus 70/30 Humalog Humulin R Humulin N 
WAC  $231.04   $41.38   $71.07   $41.38   $41.38  
GPO  $115.52   $4.44   $14.24   $4.44   $4.44  
 
The Wholesale Acquisition Cost (WAC) is always higher than the Group 
Purchasing Organization (GPO) cost due to the restriction placed on medications 
ordered within the GPO account.  To purchase from the GPO account, the medication 
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must have been used by a patient and captured via the barcode scanning software in 
place at the hospital. If a medication is wasted than the only way to order a replacement 
for that medication is to order it from the WAC account which is why Table 3 is in WAC 
dollars.  
Using retrospective data provided the capture rate for Lantus from January 2016- 
June 2016 at Good Sam was only 13.1%, meaning that only 13.1% of all Lantus 
purchased was being captured electronically and billed to the patients. The remaining 
86.9% could have still been administered to the patient just not electronically captured 
and therefore would not qualify for the GPO purchasing.  
 Table 5 illustrates the differences between the four hospital insulin management 
processes based on the four measurable objectives in the research design. While Good 
Sam keeps all the insulins in its Pyxis, the VA keeps all their insulin stored in a 
refrigerator in the medication room located in each patient ward. As was outlined in the 
literature review, keeping the insulin in the refrigerator does not increase the BUD for 
the insulin vials. Baptist Health-Richmond does a mixed approach to where they store 
their less frequently used insulins unopened in their refrigerator and then have the 
nurses mark the vials with a BUD of 28 days when they open them. This allows for the 
nursing staff to always have quick and easy access to different insulins without the 
increase in waste of unopened room temperature insulin vials expiring past their BUD.  
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Table 5: Differences in Insulin Management Processes 
 
 
Storage Administration Waste Capture Rate 
Good Sam All Pyxis Lantus- multi dose All others Patient Specific High 13.1% 
VA All Refrigerator All multi dose None 100% 
UKCMC All Pyxis All multi dose Minimal 15% 
Baptist 
Health- 
Richmond 
Mixture of 
Refrigerator 
and Omnicell1 
All multi dose Minimal Unknown 
  
The VA states that they have a 100% capture rate but that may be since they are 
on a federal billing system that is different than any other hospital and allows for them to 
have a fully integrated healthcare electronic system. UKCMC’s capture rate was very 
similar to Good Sam for January to June 2016, around 15%. However, UKCMC 
increased the capture rate in January 2017 to 58% while some data only show Good 
Sam’s capture rate increasing to 37%. In an interview, a director at UKCMC, stated that 
he believes their capture rate has increased due to the increased awareness and 
abundance of barcode stickers available for the nurses to grab and stick to the syringe 
to then scan at the bedside (Turner 2017).  
  
The waste difference is interesting to see that Good Sam has a high amount of 
waste compared to the other hospitals’ insulin management processes. This may be 
due to Good Sam being the only insulin management process that still incorporates 
patient specific 3ml vials of insulin. If a patient does not use all the insulin in their patient 
specific vial at Good Sam, then it is sent back to the pharmacy for disposal. The patient 
specific vials should remain in the patient’s medicine cart until they are discharged or all 
																																																						
1	Omnicell	is	a	different	type	of	Automated	Dispensing	Cabinet	(ADC)	similar	to	Pyxis	
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the insulin has been administered. However, it was shown that after just one use of the 
patient vials, the remaining amount was being sent back for disposal instead of stored 
away for the next days dose. The other three hospitals would share the insulin and 
utilize it as a multi-dose vial until it is empty. They would store the insulin vials in a 
common medicine room to be drawn up into a syringe and for that syringe to be taken to 
the specific patients.  UKCMC collected minimal insulin waste that could be attributed to 
less commonly used insulin types expiring due their beyond use dating and not being 
administered before that time. Baptist Health-Richmond contributed their minimal insulin 
waste to storing the less frequently used insulin types in the refrigerator until opening to 
ensure a longer date of use. However, Baptist Health-Richmond still had insulin waste 
from some of the staff drawing up doses hours before its due time and then the patient 
requiring a dosing change to where they could no longer use all the insulin they had 
previously drawn up.    
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Discussion 
 
 Different areas were looked at to determine which of the hospitals insulin 
management process was working more efficiently in that area. Looking at the results 
above, it is important to take away that each hospital insulin management process is 
different. Those differences are what helped to develop new and unique ways to alter 
the current insulin management process at Good Sam to change their administration 
techniques, increase their capture rate, decrease their waste, and overall lower the cost 
of insulin.  
 
 Good Sam could change their administration technique to where they utilize all 
insulin vials as multi-dose vials and store them in their medication rooms on each 
inpatient floor. This will allow for nurses to access these medications via the Pyxis and 
to draw up the insulin dose there and to return the insulin vial back to the Pyxis if there 
is any remaining insulin in the vial. At the same time in the Pyxis cubie with insulin vial 
can be the insulin specific barcode stickers to attach to the insulin syringe to then be 
scanned at the time of administration to increase Good Sam’s capture rate. Offering 
education to the nursing staff and ensuring that every staff member understands the 
new proper way to administer insulin and scan the correct barcode for the insulin will 
help to enhance success in the new insulin management process at Good Sam.  
 
 However, with all new process changes that occur there will be costs. There will 
now be more administrative burden placed on the nursing staff who are administering 
the insulin. Currently, they can just access the Pyxis and remove a vial and place that 
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vial in their pocket until they are ready to use it for one of their patients. With the new 
process the nurse will have to remember to bring a syringe with a needle to the Pyxis, 
along with having the exact dosing with them to ensure they are drawing up the correct 
dose, they will have to remember to attach the appropriate sticker to their syringe, and 
they will have to then store that insulin syringe and needle in a safe place until they are 
ready to properly administer it. This may lead to a detrimental effect for the patients in 
the form of medication errors if the nursing staff does not follow the new process and 
accidentally draws up the incorrect dose or gets two patients’ syringes mixed up. To 
help mitigate these errors it will be important to ensure proper training for the staff.  
 
 Utilizing each vial until it is empty will help cut down on the amount insulin waste 
that is currently being produced. If we were to take the waste data I collected for the 14 
days and extrapolate that to an average annual cost of insulin waste at Good Sam, it 
would come out to around $157,000. Utilizing multi-dose vials will help to reduce the 
estimated $157,000 in waste but is not the only route of decreasing costs for Good 
Sam. Increasing the capture rate will be essential to decreasing the overall cost. The 
$157,000 does not include extra money spent ordering the vials from the WAC account 
instead of the GPO. That cost while not estimated could be an even larger amount.  
 
 Adding the insulin specific barcodes into each cubie in the Pyxis should raise 
awareness to nurse as a reminder to scan the medication into the EMR when 
administering to the patient. Education will also play a key role for increasing the 
capture rate to ensure that all of the staff are properly trained and understand that is 
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important to capture the medication being administered at the bedside not only for the 
hospital but also to ensure that it is the right insulin being administered to the patient.  
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Conclusion 
 
  
This study was able to collect specific data and analyze the hospital insulin 
management process at Good Sam. Comparing other hospitals’ insulin management 
process to Good Sam, found that altering the way insulin is being administered and 
distributed to patients could create a positive trickle-down effect. There were three main 
areas to focus on to implement these changes. The use of multi-dose vials will be 
essential to ensure that only a minimal amount of insulin will be wasted. Increasing the 
capture rate for the insulin will help to further decrease administrative costs of the 
insulins and allow the hospital to buy the insulin at an 80%- 90% cheaper cost. While 
education will be the cornerstone in implementing the new process and ensuring that all 
of the staff is adequately instructed on their role in the new process. 
 
Changing the route of administration techniques to multi dose vials in 
combination with an increase in the capture rate through more education will lead to a 
decrease in the amount of insulin waste which will then decrease the costs currently 
associated with the insulin management process.   
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Limitations 
 
This study does have limitations that should be addressed such as not 
considering the various contracts that each hospital formulary committee may have in 
place with current distributors or drug companies to help lower their cost of drug 
acquisition in return for loyalty in using their insulin brand for their inpatients. Most 
hospitals are reluctant to discuss their contracts and some even fail to mention that they 
have one for their insulin products. There were limitations of being able to use dollar 
amounts to compare the costs of each hospital’s insulin management process to 
another. While Good Sam was willing to distribute their WAC and GPO pricing per each 
insulin vial, other hospitals were reluctant to make theirs public. This did not allow me to 
make direct comparisons in the annual costs of each insulin management process.  
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